Siemens Healthineers, a German medical equipment manufacturer, is expected to release its financial accounts for 2023/2024 on November 6. The company has faced challenges in recent quarters but is now entering the new financial year with more cautious forecasts.

The stock has been trading within a range of €45 to €55 for over two years, indicating a lack of confidence in the market. The impact of Covid-19 on Siemens Healthineers has been mixed, with the Diagnostics division experiencing significant growth while other sectors have faced difficulties. The company does not anticipate growth in major markets like China and projects zero growth for 2024/2025.

Despite these challenges, Siemens Healthineers remains the dominant player in the medical imaging market, holding approximately 55% of the market share.